Does Humana Cover Anxiety Treatment in Delaware? A 2026 Guide

Last updated: July 23, 2026

Key Facts. Humana Anxiety Coverage in Delaware (2026)
• Humana offers Medicare Advantage (MAPD) plans only in Delaware. No commercial/individual plans.
• Governing framework: CMS 42 CFR Part 422, not Delaware state parity law § 3343 (federal MA preemption applies).
• PBM: Humana Pharmacy Solutions (HPS) manages the Part D drug formulary.
• Benzodiazepines (Schedule IV) require an Electronic Prescription for Controlled Substances (EPCS) in Delaware. Schedule IV triggers DE EPCS requirements.
• Pregabalin/Lyrica (Schedule V) also requires EPCS in Delaware.
• SSRIs, SNRIs, buspirone, and hydroxyzine are non-scheduled. Delaware EPCS law is entirely inapplicable to these drugs.
• Federal appeal pathway for coverage denials: Humana redetermination → Maximus IRE (1-855-887-6668) → ALJ → MAC → Federal court. Delaware DOI external review does NOT apply to MAPD.
• Medicaid dual-eligible members (Medicare + Medicaid): LIS/Extra Help reduces Part D cost-sharing; D-SNP coordination available.
• Contacts: Humana 1-800-448-6262 | HPS 1-800-379-0092 | DE DOI 1-302-674-7300 | Delaware SHIP 1-800-336-9500

If you have Humana insurance in Delaware and are seeking anxiety treatment, this guide explains what your Medicare Advantage plan may cover in 2026. Including medications, telehealth, and how to navigate prior authorization or coverage denials.

Ready to explore anxiety treatment options? Klarity Health connects you with 2,000+ licensed providers who specialize in anxiety treatment. And can verify your Humana benefits before your first visit. See if you may qualify →

Does Humana Offer Commercial Plans in Delaware?

Humana exited the commercial individual and small-group insurance market in Delaware. In 2026, Humana in Delaware operates exclusively through Medicare Advantage Prescription Drug (MAPD) plans. If you are under 65 or not Medicare-eligible, Humana is not an option in Delaware and you should check UnitedHealthcare, Highmark BCBS, Aetna, or Cigna instead.

For Delaware Medicare beneficiaries aged 65 or older (or qualifying due to disability), Humana’s MAPD plans bundle Medicare Parts A, B, and D coverage. Including mental health benefits and prescription drug coverage. Under a single plan administered by Humana.

Governing Framework: CMS 42 CFR Part 422, Not Delaware § 3343

Delaware’s mental health parity law (Del. Code Ann. tit. 18, § 3343) sets strong parity protections for commercial insurance. However, Medicare Advantage plans are governed by federal law under 42 CFR Part 422 and the Mental Health Parity and Addiction Equity Act (MHPAEA) as implemented through CMS. Delaware’s § 3343 does not apply to MAPD plans.

What this means practically:

• Parity rights for Humana MAPD members come from CMS standards and MHPAEA, not § 3343.
• Complaints about parity violations should go to CMS (1-800-633-4227) or through Medicare’s appeals process. Not the Delaware DOI.
• Delaware DOI (1-302-674-7300) has limited MAPD jurisdiction and cannot compel coverage changes on federally regulated MA plans.
• MHPAEA still applies: Humana may not impose more restrictive prior authorization, quantity limits, or step therapy requirements on mental health benefits (including anxiety treatment) than it does on comparable medical/surgical benefits.

HPS Part D Formulary: Anxiety Medications

Humana’s prescription drug coverage for MAPD members uses the Humana Pharmacy Solutions (HPS) formulary. Below is a representative overview of common anxiety medications and their typical Part D status. Exact tiers and PA requirements vary by specific plan. Always verify with HPS at 1-800-379-0092.

Tiers and PA requirements reflect typical HPS Part D formulary structure. Confirm your specific plan’s formulary at humana.com or by calling HPS at 1-800-379-0092.

Delaware EPCS Requirements: What Humana Members Must Know

Delaware’s Electronic Prescribing for Controlled Substances (EPCS) law (DE Admin Code Title 24 § 1700) requires that all Schedule II. V controlled substances be prescribed electronically. For anxiety treatment, this has the following impact:

Key takeaway: The vast majority of anxiety medications prescribed via telehealth. SSRIs, SNRIs, buspirone, and hydroxyzine. Are non-scheduled and face no Delaware EPCS barrier whatsoever. Benzodiazepines and pregabalin require EPCS but can still be prescribed via telehealth by properly credentialed providers on EPCS-capable platforms.

Prior Authorization for Anxiety Medications Under HPS

Under the HPS Part D formulary, most first-line anxiety medications (generic SSRIs, SNRIs, buspirone, hydroxyzine) do not require prior authorization. PA requirements are more common for controlled substances and higher-tier drugs. Here is how the PA process works if PA is required:

1. Obtain documentation: Your provider should document the anxiety diagnosis, symptom severity, and any prior medication trials.
2. Provider submits PA request to HPS: Contact HPS at 1-800-379-0092 or submit through the electronic PA portal.
3. HPS clinical review: Typically 24. 72 hours for standard requests; urgent requests reviewed within 24 hours.
4. PA criteria for benzodiazepines: HPS typically requires documented diagnosis of anxiety disorder, provider attestation that the benefit outweighs the risk of dependence, and a quantity limit per fill.
5. PA criteria for pregabalin: Documentation of anxiety diagnosis (generalized anxiety disorder is an FDA-approved indication) and may require a prior trial of an SSRI or SNRI.

Peer-to-peer review tip: If HPS denies a PA request, your provider can request a peer-to-peer review with the HPS medical director within 24 hours of denial. Peer-to-peer reviews resolve many routine PA denials when clinical documentation is thorough.

MHPAEA Parity Rights for Humana MAPD Members

While Delaware § 3343 does not directly govern MAPD plans, federal MHPAEA protections still apply to Humana Medicare Advantage plans under CMS 42 CFR Part 422. Humana may not impose:

• More restrictive prior authorization requirements on anxiety treatment than on comparable medical/surgical benefits.
• Lower day or visit limits for mental health treatment than for medical conditions.
• Higher cost-sharing (copays/coinsurance) for mental health drugs than for comparable medical drugs.
• Non-quantitative treatment limitations (NQTLs). Such as fail-first step therapy. That are not applied equivalently to medical conditions.

If you believe Humana is violating MHPAEA, file a complaint with CMS at 1-800-633-4227 or at medicare.gov. You may also contact the Delaware SHIP (State Health Insurance Assistance Program) at 1-800-336-9500 for free counseling on your Medicare rights.

Delaware EPCS and Telehealth: What This Means for Anxiety Treatment

Klarity Health’s 2,000+ licensed providers are equipped to prescribe anxiety medications via telehealth. Here is what Humana MAPD members in Delaware should know:

• SSRIs, SNRIs, buspirone, and hydroxyzine can be prescribed at a standard telehealth visit with no EPCS or DEA special-registration barriers. These first-line agents cover most anxiety presentations and are fully compatible with telehealth-first care.
• Benzodiazepines (Schedule IV) require DE EPCS at the provider level. Under the Ryan Haight Act, prescribing controlled substances via telemedicine generally requires an in-person exam unless a DEA telemedicine exception applies. Providers on EPCS-enabled platforms can fulfill the DE EPCS requirement electronically.
• Pregabalin (Schedule V) similarly requires DE EPCS. For generalized anxiety disorder (a labeled indication), pregabalin is prescribable via telehealth by providers with DEA Schedule V registration on EPCS-capable systems.
• Humana’s telehealth benefit (included in MAPD plans) may cover the visit cost separately from the pharmacy benefit. Verify your plan’s telehealth copay with Humana at 1-800-448-6262.

Medicaid and Dual-Eligible Members

Some Delaware Medicare beneficiaries are also enrolled in Medicaid (Delaware Medical Assistance Program. DMAP), making them dual-eligible. Humana offers Dual Eligible Special Needs Plans (D-SNP) in Delaware that coordinate Medicare Advantage and Medicaid benefits:

• Low Income Subsidy (LIS/Extra Help): Eligible dual-eligible members may qualify for Extra Help, which significantly reduces Part D premiums and copays for medications including anxiety drugs.
• D-SNP coordination: Humana D-SNP plans coordinate Medicare and Medicaid benefits to minimize cost-sharing gaps for mental health services.
• DMAP contact: Delaware Medical Assistance Program (DMAP) at 1-800-372-2022 or at dhss.delaware.gov.
• Important disclaimer: If you receive full Medicaid benefits, your primary coverage for mental health services may be through Medicaid, not Medicare Part B. Verify your coordination-of-benefits arrangement with both Humana (1-800-448-6262) and DMAP (1-800-372-2022).

How to Appeal a Humana Coverage Denial for Anxiety Treatment

For MAPD members, all coverage appeals follow the federal Medicare appeals process. Not Delaware state external review. There are five levels:

1. Level 1. Humana Redetermination: Submit a written appeal to Humana within 60 days of the denial notice. Humana must respond within 7 days for standard requests (72 hours for expedited). Contact: 1-800-448-6262.
2. Level 2. Maximus IRE (Independent Review Entity): If Humana upholds the denial, it is automatically forwarded to Maximus (the CMS-contracted IRE). Contact Maximus IRE at 1-855-887-6668. Maximus reviews within 14 days (7 days for expedited).
3. Level 3. Office of Medicare Hearings and Appeals (ALJ): If the contested amount meets the threshold (approximately $180 in 2026), you may request an ALJ hearing within 60 days of the Maximus decision.
4. Level 4. Medicare Appeals Council (MAC): If the ALJ rules against you, appeal to the MAC within 60 days.
5. Level 5. Federal District Court: If the MAC upholds the denial and the amount at issue meets the federal court threshold, you may file in federal district court.

Important: Delaware DOI (1-302-674-7300) cannot compel coverage changes for MAPD plans. For MAPD regulatory complaints, contact CMS at 1-800-633-4227 or file online at medicare.gov.

How Humana Compares to Other Delaware Insurers for Anxiety Coverage

Key difference: Humana DE MAPD members lose access to Delaware § 3343 state parity enforcement and instead rely on CMS/MHPAEA federal protections. The practical benefit coverage (SSRIs, SNRIs) is comparable, but the appeals pathway is entirely federal.

How to Verify Your Humana Anxiety Coverage in Delaware

1. Locate your Summary of Benefits: Log into humana.com or call 1-800-448-6262 to find your specific 2026 MAPD plan’s Summary of Benefits.
2. Check the HPS Part D formulary: Call HPS at 1-800-379-0092 or search the formulary online for your specific anxiety medications. Confirm tier, PA requirements, and quantity limits.
3. Confirm telehealth benefits: Ask Humana whether your plan covers telehealth mental health visits and what the applicable copay or coinsurance is.
4. Verify EPCS status with your provider: If benzos or pregabalin are being considered, confirm your Klarity provider is using an EPCS-enabled platform.
5. Contact Delaware SHIP if needed: For free, unbiased Medicare benefits counseling, contact SHIP at 1-800-336-9500.

Frequently Asked Questions

Does Humana cover therapy for anxiety in Delaware?

Humana MAPD plans typically cover outpatient mental health visits (therapy and psychiatry) under Medicare Part B. Cost-sharing (copay or coinsurance) applies. Telehealth mental health visits are also typically covered. Verify the specific copay for mental health office visits in your 2026 plan’s Summary of Benefits.

Does Humana cover SSRIs and SNRIs for anxiety in Delaware?

Yes, SSRIs and SNRIs are generally covered on the HPS Part D formulary at Tier 1. 2 with no prior authorization required. These are the most common first-line medications for anxiety disorders and are available via telehealth without any EPCS barrier.

Can Humana require step therapy for anxiety medications?

Yes, step therapy (fail-first requirements) may apply for higher-tier medications such as pregabalin or certain brand-name agents. However, under MHPAEA, Humana may not apply step therapy to anxiety medications more restrictively than it does to comparable medical/surgical drugs. If you believe a step therapy requirement violates parity, you may file a complaint with CMS at 1-800-633-4227.

What is the Maximus IRE and when do I use it?

Maximus is the CMS-contracted Independent Review Entity (IRE) for Medicare Advantage coverage appeals. If Humana denies your coverage request or appeal (redetermination), the case is automatically forwarded to Maximus for a second-level independent review. Contact Maximus at 1-855-887-6668 if you need to follow up on a pending IRE review.

Does Delaware § 3343 mental health parity law apply to my Humana plan?

No. Delaware’s § 3343 applies to commercial (non-Medicare) insurance plans regulated by the Delaware DOI. Humana’s Medicare Advantage plans in Delaware are federally regulated under CMS 42 CFR Part 422 and MHPAEA. Parity complaints for MAPD plans must go through CMS, not the Delaware DOI.

Is buspirone covered under Humana’s HPS formulary?

Yes, buspirone (a non-controlled, non-scheduled medication) is typically covered at Tier 1 on the HPS formulary with no prior authorization required. It is a common first-line option for generalized anxiety disorder and presents no EPCS or DEA barrier for telehealth prescribing.

Contact Information

• Humana Member Services: 1-800-448-6262 (TTY: 711)
• Humana Pharmacy Solutions (HPS): 1-800-379-0092
• Delaware DOI (limited MAPD jurisdiction): 1-302-674-7300
• Delaware SHIP (free Medicare counseling): 1-800-336-9500
• Maximus IRE (Level 2 Medicare appeal): 1-855-887-6668
• CMS Medicare helpline: 1-800-633-4227
• Delaware Medical Assistance Program (DMAP): 1-800-372-2022

Disclaimer: Coverage details described in this guide reflect general HPS formulary structures and CMS requirements as of 2026. Actual coverage, prior authorization criteria, and cost-sharing vary by specific Humana MAPD plan. Coverage information may change; always verify benefits directly with Humana (1-800-448-6262) or HPS (1-800-379-0092) before scheduling treatment. This guide does not constitute legal, medical, or insurance advice. Klarity Health is not affiliated with Humana or HPS.

Connect with a licensed anxiety specialist today. Klarity Health’s 2,000+ licensed providers accept a wide range of insurance plans and can help you verify your Humana benefits before your first visit. See if you may qualify →